MEDIA

Publications

Poster: Phase Ia/Ib study of RS-0139 a novel tumor-targeted delivery of docetaxel, in patients with recurrent, locally advanced, or metastatic non-small cell lung cancer

European Society for Medical Oncology 2022 Congress

September 2022